Brought to you by 
Sosei buys Arakis for £106.5mm
29 Jun 2006
Executive Summary
As part of its effort to move into the top-ten list of biopharmaceutical firms worldwide, Japanese pharma company Sosei Ltd. Co. has agreed to acquire all of the shares of privately held Arakis Ltd. (inflammatory diseases, cancer, and pain) for £106.5mm ($186.1mm) in cash and stock.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sosei buys Arakis for £106.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice